Susquehanna International Group’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Susquehanna International Group’s Portfolio GRTX Stock Details GRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-41,100	Closed	-$128K	–	13258
2023 Q2	$128K	Sell	41,100 -158,400	-79%	-$471K	﹤0.01%	10733
2023 Q1	$511K	Buy	199,500 +182,300	+1,060%	+$376K	﹤0.01%	8513
2022 Q4	$25.6K	Sell	17,200 -4,100	-19%	-$6.65K	﹤0.01%	11678
2022 Q3	$37K	Buy	21,300 +800	+4%	+$1.13K	﹤0.01%	12372
2022 Q2	$27K	Sell	20,500 -270,600	-93%	-$463K	﹤0.01%	12275
2022 Q1	$693K	Sell	291,100 -122,500	-30%	-$319K	﹤0.01%	8113
2021 Q4	$1.9M	Buy	+413,600	New	+$1.37M	﹤0.01%	5629

Other funds holding GRTX

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Susquehanna International Group's GRTX Position: Q2 2024 in Review

Susquehanna International Group sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q2 2024, closing a stake of 286,180 shares — an estimated $40.1K sold.

Susquehanna International Group first reported a position in GRTX in Q4 2021 and held it in 9 quarters. The position peaked at $671K in Q4 2021. 1 fund tracked by Wall St. Rank holds GRTX as of Q2 2024.

Susquehanna International Group reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Susquehanna International Group sold 286,180 Galera Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $40.1K.
Susquehanna International Group first reported a position in Galera Therapeutics, Inc. Common Stock in Q4 2021 and held it in 9 quarters.
Susquehanna International Group's Galera Therapeutics, Inc. Common Stock position peaked at $671K in Q4 2021.
1 fund tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q2 2024.

Based on Susquehanna International Group's 13F filing for Q2 2024, filed 15 Aug 2024.